ArticleJournal of thoracic disease2024

Treatment-related adverse events of combination chemoimmunotherapy versus chemotherapy alone in first-line treatment for non-small cell lung cancer: a systematic review and meta-analysis of randomized clinical trials.

Kazuki Takada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.